Marketing-authorisation holder · Canada
Cipher Pharmaceuticals Inc
13 medicines in 1 country, as authorisation holder.
Group structure
Part of
CipherPharmaceutical groupOther companies in the group
United States1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
13 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACTIKERALL0.5 % / w/w + 10 % / w/w · Solution | Fluorouracil, Salicylic acid | Canada | Marketed | 2016 |
| AGGRASTAT12.5 mg / 250 ml · Solution | Tirofiban | Canada | Marketed | 2002 |
| BRINAVESS20 mg / ml · Solution | Vernakalant | Canada | Marketed | 2018 |
| DURELA300 mg · Capsule (Extended-Release) | Tramadol | Canada | Marketed | 2012 |
| DURELA200 mg · Capsule (Extended-Release) | Tramadol | Canada | Marketed | 2012 |
| DURELA100 mg · Capsule (Extended-Release) | Tramadol | Canada | Marketed | 2012 |
| EPURIS20 mg · Capsule | Isotretinoin | Canada | Marketed | 2013 |
| EPURIS40 mg · Capsule | Isotretinoin | Canada | Marketed | 2013 |
| EPURIS10 mg · Capsule | Isotretinoin | Canada | Marketed | 2013 |
| EPURIS30 mg · Capsule | Isotretinoin | Canada | Marketed | 2013 |
| VANIQA13.9 % / w/w · Cream | Eflornithine | Canada | Marketed | 2005 |
| FENOMAX100 mg · Capsule | Fenofibrate | Canada | Cancelled | |
| FENOMAX160 mg · Capsule | Fenofibrate | Canada | Cancelled | 2006 |